ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Results: 1-25/128

ACNEIFORM DERMATOSES

Authors: PLEWIG G JANSEN T

Citation: G. Plewig et T. Jansen, ACNEIFORM DERMATOSES, Dermatology, 196(1), 1998, pp. 102-107

TREATMENT OF PSORIASIS WITH VITAMIN-D-3 DERIVATIVES AND 311-NM UVB

Authors: ROCKEN M MESSER G PLEWIG G

Citation: M. Rocken et al., TREATMENT OF PSORIASIS WITH VITAMIN-D-3 DERIVATIVES AND 311-NM UVB, Journal of dermatological treatment, 9, 1998, pp. 37-40

INCIDENCE OF STREPTOCOCCUS-PNEUMONIAE INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

Authors: GUENTHER C HOLLER E MUTH A HUMANN M LEDDEROSE G HAHN J WICK M ROECKEN M PLEWIG G WILMANNS W KOLB HJ

Citation: C. Guenther et al., INCIDENCE OF STREPTOCOCCUS-PNEUMONIAE INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 499-499

LUPUS-ERYTHEMATOSUS IN CARRIERS OF X-LINKED CHRONIC GRANULOMATOUS-DISEASE

Authors: PETROPOULOU T RUPEC RA WALCHNER M LIESE J PLEWIG G MESSER G BELOHRADSKY BH

Citation: T. Petropoulou et al., LUPUS-ERYTHEMATOSUS IN CARRIERS OF X-LINKED CHRONIC GRANULOMATOUS-DISEASE, Molecular immunology, 35(11-12), 1998, pp. 762-762

PUVA INHIBITS DNA-REPLICATION, BUT NOT GENE-TRANSCRIPTION AT NONLETHAL DOSAGES

Authors: LUFTL M ROCKEN M PLEWIG G DEGITZ K

Citation: M. Luftl et al., PUVA INHIBITS DNA-REPLICATION, BUT NOT GENE-TRANSCRIPTION AT NONLETHAL DOSAGES, Journal of investigative dermatology, 111(3), 1998, pp. 399-405

CONSTRUCTION OF A TISSUE-SPECIFIC I-KAPPA-B-ALPHA KNOCK-OUT MOUSE

Authors: RUPEC RA RAMISCH S PLEWIG G PFEFFER K MESSER G

Citation: Ra. Rupec et al., CONSTRUCTION OF A TISSUE-SPECIFIC I-KAPPA-B-ALPHA KNOCK-OUT MOUSE, Journal of investigative dermatology, 110(4), 1998, pp. 604-604

SERUM ANTIBODIES TO HELICOBACTER-PYLORI IN ROSACEA PATIENTS

Authors: NEUBERT U JANSEN T PLEWIG G

Citation: U. Neubert et al., SERUM ANTIBODIES TO HELICOBACTER-PYLORI IN ROSACEA PATIENTS, Journal of investigative dermatology, 110(4), 1998, pp. 671-671

EARLY AND LATE EVENTS FOLLOWING PHOTOTESTING OF CUTANEOUS AND SYSTEMIC SUBTYPES OF LUPUS-ERYTHEMATOSUS

Authors: WAICHNER M MESSER G SALOMON N KIND P PLEWIG G ROCKEN M

Citation: M. Waichner et al., EARLY AND LATE EVENTS FOLLOWING PHOTOTESTING OF CUTANEOUS AND SYSTEMIC SUBTYPES OF LUPUS-ERYTHEMATOSUS, Journal of investigative dermatology, 110(4), 1998, pp. 697-697

COMBINATION OF TACALCITOL WITH UVB 311 NM - ANALYSIS OF CLINICAL RESPONSIVENESS AND VITAMIN-D-RECEPTOR (VDR) POLYMORPHISM

Authors: MESSER G DIEDERICH R DEGITZ K PLEWIG G ROCKEN M

Citation: G. Messer et al., COMBINATION OF TACALCITOL WITH UVB 311 NM - ANALYSIS OF CLINICAL RESPONSIVENESS AND VITAMIN-D-RECEPTOR (VDR) POLYMORPHISM, Journal of investigative dermatology, 110(4), 1998, pp. 700-700

USE OF ISOTRETINOIN FOR INFLAMMATORY BOWEL-DISEASE

Authors: JANSEN T PLEWIG G

Citation: T. Jansen et G. Plewig, USE OF ISOTRETINOIN FOR INFLAMMATORY BOWEL-DISEASE, Hautarzt, 49(8), 1998, pp. 672-673

THE KEINING SIGN IN DERMATOMYOSITIS

Authors: KUNTE C PLEWIG G

Citation: C. Kunte et G. Plewig, THE KEINING SIGN IN DERMATOMYOSITIS, Hautarzt, 49(7), 1998, pp. 596-597

INPATIENT BEHAVIORAL MEDICINE FOR CHRONIC SKIN DISEASES

Authors: HOEGL L FICHTER M PLEWIG G

Citation: L. Hoegl et al., INPATIENT BEHAVIORAL MEDICINE FOR CHRONIC SKIN DISEASES, Hautarzt, 49(4), 1998, pp. 270-275

BOTULINUM TOXIN-A IN DERMATOLOGY

Authors: HECKMANN M CEBALLOSBAUMANN A SCHALLER M PLEWIG G

Citation: M. Heckmann et al., BOTULINUM TOXIN-A IN DERMATOLOGY, Hautarzt, 49(2), 1998, pp. 87-90

AXILLARY HYPERHIDROSIS - SUCCESSFUL TREAT MENT WITH BOTULINUM TOXIN-A

Authors: HECKMANN M BREIT S CEBALLOSBAUMANN A SCHALLER M PLEWIG G

Citation: M. Heckmann et al., AXILLARY HYPERHIDROSIS - SUCCESSFUL TREAT MENT WITH BOTULINUM TOXIN-A, Hautarzt, 49(2), 1998, pp. 101-103

NARROW-SPECTRUM UVB 311 NM VERSUS BROAD-SPECTRUM UVB - NEW DEVELOPMENTS IN PHOTOTHERAPY

Authors: DEGITZ K MESSER G PLEWIG G ROCKEN M

Citation: K. Degitz et al., NARROW-SPECTRUM UVB 311 NM VERSUS BROAD-SPECTRUM UVB - NEW DEVELOPMENTS IN PHOTOTHERAPY, Hautarzt, 49(10), 1998, pp. 795-806

ACNE FULMINANS

Authors: JANSEN T PLEWIG G

Citation: T. Jansen et G. Plewig, ACNE FULMINANS, International journal of dermatology, 37(4), 1998, pp. 254-257

ACNE INVERSA

Authors: JANSEN T PLEWIG G

Citation: T. Jansen et G. Plewig, ACNE INVERSA, International journal of dermatology, 37(2), 1998, pp. 96-100

OPTIMIZING BOTULINUM TOXIN THERAPY FOR HYPERHIDROSIS

Authors: HECKMANN M SCHALLER M PLEWIG G CEBALLOSBAUMANN A

Citation: M. Heckmann et al., OPTIMIZING BOTULINUM TOXIN THERAPY FOR HYPERHIDROSIS, British journal of dermatology, 138(3), 1998, pp. 553-554

BOTULINUM BEYOND WRINKLES

Authors: HECKMANN M SCHALLER M CEBALLOSBAUMANN A PLEWIG G

Citation: M. Heckmann et al., BOTULINUM BEYOND WRINKLES, Dermatologic surgery, 23(12), 1997, pp. 1221-1222

SAFETY OF CYPROTERONE-ACETATE - REPORT OF ACTIVE SURVEILLANCE

Authors: HEINEMANN LAJ WILLSHAHAB L VANKESTEREN P GOOREN LJG QUAST A PIETSCH H KONRAD N HELGE H GRUTERS A KNAPPE G VENTZ M PRANGE G UBELHACK R BANASCHAK K CAVALLARI C MACRELLI S HINKEL GK JUSTUS B SAREMBE B ABUSCHENKO E MOESLER T SCHINDLER AE REGIDUR PA MADJIDIAN K BRAENDLE LW KLEINKAUFHOUCKEN A HORN HJ MICHEL W MORLOT M VEISMANN S ZIEGLER R KREMPIEN R ALENFELD F HEINRICH U SIPPELL WG WILLE R LASCHET R ALEXANDER H GLANDER HJ SCHWARZE I HOEPFFNER W DIEDRICH K SCHILL T HEISE HR LEHNERT H SCHLICHTHAAR H WEISE W GERLOFF C NICKEL I BURMANNREUTER H KRAUSE W FLOHR J PLEWIG G WOLF H SCHWARZ HP BECKER A SCHMIDT C SIEGELALMASRY E MIX M OTTERMANN B RANKE MB GRAUER ML TELLER W HOMOKI J WALDHAUSER F KAISER E BALJER E EIDEN R OTT F

Citation: Laj. Heinemann et al., SAFETY OF CYPROTERONE-ACETATE - REPORT OF ACTIVE SURVEILLANCE, Pharmacoepidemiology and drug safety, 6(3), 1997, pp. 169-178

RETINOIDS IN LICHEN-PLANUS

Authors: PLEWIG G

Citation: G. Plewig, RETINOIDS IN LICHEN-PLANUS, Dermatology, 194(3), 1997, pp. 311-312

TOPICAL QUINOLONE NADIFLOXACIN (OPC-7251) IN BACTERIAL SKIN-DISEASE -CLINICAL-EVALUATION IN A MULTICENTER OPEN TRIAL AND IN-VITRO ANTIMICROBIOLOGICAL SUSCEPTIBILITY TESTING

Authors: HAUSTEIN UF NENOFF P HITTEL N KLOVEKORN W KRIEG T PLEWIG G PONCEPOSCHL E RUZICKA T TANNENBERG H THUMMES R WOLFF H

Citation: Uf. Haustein et al., TOPICAL QUINOLONE NADIFLOXACIN (OPC-7251) IN BACTERIAL SKIN-DISEASE -CLINICAL-EVALUATION IN A MULTICENTER OPEN TRIAL AND IN-VITRO ANTIMICROBIOLOGICAL SUSCEPTIBILITY TESTING, Journal of dermatological treatment, 8(2), 1997, pp. 87-92

PHOTOTESTING FOR POLYMORPHIC LIGHT ERUPTION (PLE) WITH CONSECUTIVE UVA1 UVB-IRRADIATION/

Authors: SALOMON N MESSER G DICK D PLEWIG G ROCKEN M

Citation: N. Salomon et al., PHOTOTESTING FOR POLYMORPHIC LIGHT ERUPTION (PLE) WITH CONSECUTIVE UVA1 UVB-IRRADIATION/, Photodermatology, photoimmunology & photomedicine, 13(3), 1997, pp. 72-74

PATHOGENESIS AND TREATMENT OF ACNE IN CHILDHOOD

Authors: JANSEN T BURGDORF WHC PLEWIG G

Citation: T. Jansen et al., PATHOGENESIS AND TREATMENT OF ACNE IN CHILDHOOD, Pediatric dermatology, 14(1), 1997, pp. 17-21

THE TREATMENT OF ROSACEOUS LYMPHEDEMA

Authors: JANSEN T PLEWIG G

Citation: T. Jansen et G. Plewig, THE TREATMENT OF ROSACEOUS LYMPHEDEMA, Clinical and experimental dermatology, 22(1), 1997, pp. 57-57

Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>